Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.96
-0.25 (-4.03%)
At close: May 22, 2026, 4:00 PM EDT
6.00
+0.04 (0.67%)
After-hours: May 22, 2026, 5:31 PM EDT
Journey Medical Market Cap
Journey Medical has a market cap or net worth of $164.11 million as of May 22, 2026. Its market cap has increased by 3.16% in one year.
Market Cap
164.11M
Enterprise Value
162.35M
1-Year Change
3.16%
Ranking
Category
Stock Price
$5.96
Market Cap Chart
Since the IPO on November 12, 2021, Journey Medical's market cap has increased from $157.79M to $164.11M, an increase of 4.00%. That is a compound annual growth rate of 0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 164.11M | -21.56% |
| Dec 31, 2025 | 209.22M | 156.14% |
| Dec 31, 2024 | 81.68M | -23.38% |
| Dec 29, 2023 | 106.61M | 212.54% |
| Dec 30, 2022 | 34.11M | -61.94% |
| Dec 31, 2021 | 89.63M | -43.20% |
| Nov 12, 2021 | 157.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 342.27M |
| SIGA Technologies | 335.67M |
| Akebia Therapeutics | 273.62M |
| Alpha Teknova | 208.56M |
| Aurora Cannabis | 204.97M |
| Anika Therapeutics | 197.99M |
| Lifecore Biomedical | 184.92M |
| Organigram Global | 158.78M |